<?xml version="1.0" encoding="UTF-8"?>
<p id="par0005">Since the first identified case of Coronavirus Disease (COVID-19) in December 2019, the number of confirmed cases has dramatically increased all over the world, and as of April 21â€‰st 2020, more than 2,397,216 cases worldwide have been confirmed, with, unfortunately, a rising death toll [
 <xref rid="bib0005" ref-type="bibr">1</xref>,
 <xref rid="bib0010" ref-type="bibr">2</xref>]. COVID-19 is caused by a novel coronavirus called Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) with droplets and contact being the main route of transmission. Recently an airborne transmission route has been suggested [
 <xref rid="bib0015" ref-type="bibr">3</xref>,
 <xref rid="bib0020" ref-type="bibr">4</xref>]. Although 80% of infected people experience mild to moderate disease, the other 20% present severe cases leading to critically ill patients that represent a real concern due to the rapid spread of the virus and limited medical resources even in high income countries. The result has been an enormous challenge placed on the shoulders of healthcare systems [
 <xref rid="bib0025" ref-type="bibr">5</xref>,
 <xref rid="bib0030" ref-type="bibr">6</xref>]. With the higher mortality rate among severe and critically ill patients, and the relatively high rate of transmission, not to mention the economic burden and the absence of an effective vaccine, the need for an urgent and effective treatment proves urgently crucial. Several potential treatments have been proposed, and some have even been tested or still in ongoing trials [
 <xref rid="bib0030" ref-type="bibr">6</xref>,
 <xref rid="bib0035" ref-type="bibr">7</xref>].
</p>
